NDC 0024-5869-01 - TOUJEO
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0024-5869
- Requested NDC
- 0024-5869-01
- Package NDCs from labels
- 0024-5869-01, 0024-5869-03, 0024-5869-00
- Manufacturer
- Sanofi-Aventis U.S. LLC | Sanofi-Aventis Deutschland GmbH | Genzyme Corporation
- Effective date
- 2025-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TOUJEO - Sanofi-Aventis U.S. LLC | Sanofi-Aventis Deutschland GmbH | Genzyme Corporation | Sanofi-Aventis U.S. LLC | Sanofi-Aventis Deutschland GmbH | Genzyme Corporation | 2025-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
| TOUJEO - A-S Medication Solutions | A-S Medication Solutions | 2023-04-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0024-5869-00 | TOUJEO | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 25 | |
| 0024-5869-00 | TOUJEO | 1.5 mL in 1 SYRINGE | INJECTION, SOLUTION | 1.5 | 25 | |
| 0024-5869-01 | TOUJEO | 1.5 mL in 1 SYRINGE | INJECTION, SOLUTION | 1.5 | 25 | |
| 0024-5869-03 | TOUJEO | 3 in 1 CARTON | INJECTION, SOLUTION | 3 | 25 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0024-5869 | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION TOUJEO MAX (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 24 | Current NDC, Legacy NDC, 4 package rows | 20250319_c9561d96-124d-48ca-982f-0aa1575bff36.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0024-5869-00 | ML - Milliliter | 0024-5869 | 37c667e4-ce5b-4f9f-8bf7-b7ff3b00070c | 1 | 2021-06-02 |
| 0024-5869-01 | ML - Milliliter | 0024-5869 | 43f5217b-8e34-49dd-b0be-c1b2d5a05a97 | 1 | 2017-11-06 |
| 0024-5869-03 | ML - Milliliter | 0024-5869 | ce96366d-7fde-4e4b-92ff-e6cdc6ac9ef7 | 1 | 2015-03-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| insulin glargine | ACTIVE INGREDIENT | 2ZM8CX04RZ | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 7 | |
| insulin glargine | ACTIVE MOIETY | 2ZM8CX04RZ | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 7 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 7 | |
| metacresol | INACTIVE INGREDIENT | GGO4Y809LO | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 7 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 7 | |
| zinc | INACTIVE INGREDIENT | J41CSQ7QDS | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Varicose Veins | ELAPS CORALLINUS, CROTALUS HORRIDUS, BRYONIA, CALC. FLUOR., CARDUUS MAR., CHOLESTERINUM, CINCHONA, DIGITALIS, HAMAMELIS, HYDROFLUORICUM ACIDUM, LACHESIS, LYCOPODIUM, NAJA, PULSATILLA, VIPERA BERUS, ZINC. MET., AESCULUS HIPP., ECHINACEA | Newton Laboratories, Inc. | 91e8e37c-c654-6df9-e053-2995a90aafe1 | 2026-01-29 | Warnings | J41CSQ7QDS |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 49771efa-6682-51d0-e063-6294a90a18a5 | 2026-01-28 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 497763ee-dc70-bb48-e063-6294a90afb3d | 2026-01-28 | Warnings | PDC6A3C0OX |
| Insulin Glargine | INSULIN GLARGINE-YFGN | Biocon Biologics Inc. | 3ac85ebb-5594-59c8-77fd-df254329d151 | 2026-01-23 | Warnings, Adverse reactions | 2ZM8CX04RZ |
| Neurotox | AGARICUS MUSCARIUS, COCCUS CACTI, CONIUM MACULATUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, ALUMINIUM METALLICUM, ANTIMONIUM CRUDUM, ARGENTUM METALLICUM, ARSENICUM ALBUM, AURUM METALLICUM, BARYTA CARBONICA, BERYLLIUM METALLICUM, BISMUTHUM METALLICUM, BORON, BROMIUM, CADMIUM METALLICUM CERIUM METALLICUM, CESIUM CHLORIDE, CHROMIUM, COBALTUM METALLICUM, CUPRUM METALLICUM, DYSPROSIUM METALLICUM, ERBIUM METALLICUM, EUROPIUM METALLICUM, FERRUM METALLICUM, GADOLINIUM METALLICUM, GERMANIUM SESQUIOXIDE, HOLMIUM METALLICUM, | BioActive Nutritional, Inc. | 73fb4038-40b5-4b5b-8ded-f510d0411c95 | 2026-01-21 | Warnings | J41CSQ7QDS |
| INSULIN DILUTING MEDIUM FOR Kirsty | WATER | Biocon Biologics Inc. | 3db1d482-7e1f-aec6-79ef-3f305b4d8277 | 2026-01-20 | Warnings, Adverse reactions | 059QF0KO0R |
| Lemon Glycerin | GLYCERIN | Jianerkang Medical Co., Ltd | edee14da-13d8-4bc2-9c37-cfc353763d11 | 2026-01-16 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Cream | HEMORRHOIDAL CREAM | Walgreens | 1ac2b2ae-c090-483b-ad2c-1374552add4a | 2026-01-15 | Warnings | PDC6A3C0OX |
| Walgreens Adult Glycerin Laxative | GLYCERIN SUPPOSITORY | Walgreens | f19c6cca-e763-4c38-a546-855f027d20c5 | 2026-01-15 | Warnings | PDC6A3C0OX |
| Walgreens Adult Glycerin Laxative | GLYCERIN SUPPOSITORY | Walgreens | 1a00ff43-ba79-4339-a547-f9757872958b | 2026-01-15 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Cream | HEMORRHOIDAL CREAM | Walgreens | 4276ddad-2363-462a-bb97-574f946ec3f0 | 2026-01-15 | Warnings | PDC6A3C0OX |
| Hemorrhoid and Fissure | GLYCERIN 6%,LIDOCAINE 4%,ECTOIN 0.12% | FlexiGo Inc | 48697377-61c0-1b0a-e063-6294a90a3293 | 2026-01-15 | Warnings | PDC6A3C0OX |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-01-14 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.